XML 66 R12.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value Measures
6 Months Ended
Apr. 30, 2015
Fair Value Disclosures [Abstract]  
Fair Value Measures
Fair Value Measures
Accounting Standards Codification (ASC) 820-10, Fair Value Measurements and Disclosures, defines fair value, establishes guidelines and enhances disclosure requirements for fair value measurements. The accounting guidance requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The accounting guidance also establishes a fair value hierarchy based on the independence of the source and objective evidence of the inputs used. There are three fair value hierarchies based upon the level of inputs that are significant to fair value measurement:
Level 1—Observable inputs that reflect quoted prices (unadjusted) for identical instruments in active markets;
Level 2—Observable inputs other than quoted prices included in Level 1 for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-driven valuations in which all significant inputs and significant value drivers are observable in active markets; and
Level 3—Unobservable inputs to the valuation derived from fair valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
On a recurring basis, the Company measures the fair value of certain of its assets and liabilities, which include cash equivalents, short-term investments, non-qualified deferred compensation plan assets, and foreign currency derivative contracts.
The Company’s cash equivalents and short-term investments are classified within Level 1 or Level 2 because they are valued using quoted market prices in an active market or alternative independent pricing sources and models utilizing market observable inputs.
The Company’s non-qualified deferred compensation plan assets consist of money market and mutual funds invested in domestic and international marketable securities that are directly observable in active markets and are therefore classified within Level 1.
The Company’s foreign currency derivative contracts are classified within Level 2 because these contracts are not actively traded and the valuation inputs are based on quoted prices and market observable data of similar instruments.
The Company’s borrowings under its credit and term loan facilities are classified within Level 2 because these borrowings are not actively traded and have a variable interest rate structure based upon market rates currently available to the Company for debt with similar terms and maturities. Refer to Note 7. Credit Facility.

Assets and Liabilities Measured at Fair Value on a Recurring Basis
Assets and liabilities measured at fair value on a recurring basis are summarized below as of April 30, 2015:
 
 
 
Fair Value Measurement Using
Description
Total
 
Quoted Prices in Active
Markets for  Identical Assets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable Inputs
(Level 3)
 
(in thousands)
Assets
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
Money market funds
$
394,546

 
$
394,546

 
$

 
$

Commercial paper
3,399

 

 
3,399

 

Short-term investments:
 
 
 
 
 
 
 
U.S. government agency securities
24,912

 

 
24,912

 

Municipal bonds
1,406

 

 
1,406

 

Certificates of deposit
5,950

 

 
5,950

 

Commercial paper
5,893

 

 
5,893

 

Corporate debt securities
67,845

 

 
67,845

 

Asset-backed securities
30,573

 

 
30,573

 

Prepaid and other current assets:
 
 
 
 
 
 
 
Foreign currency derivative contracts
13,666

 

 
13,666

 

Other long-term assets:
 
 
 
 
 
 
 
Deferred compensation plan assets
157,537

 
157,537

 

 

Total assets
$
705,727

 
$
552,083

 
$
153,644

 
$

Liabilities
 
 
 
 
 
 
 
Accounts payable and accrued liabilities:
 
 
 
 
 
 
 
Foreign currency derivative contracts
$
19,103

 
$

 
$
19,103

 
$

Total liabilities
$
19,103

 
$

 
$
19,103

 
$


Assets and liabilities measured at fair value on a recurring basis are summarized below as of October 31, 2014:
 
 
 
Fair Value Measurement Using
Description
Total
 
Quoted Prices in Active
Markets for  Identical Assets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable Inputs
(Level 3)
 
(in thousands)
Assets
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
Money market funds
$
409,064

 
$
409,064

 
$

 
$

Prepaid and other current assets:
 
 
 
 
 
 
 
Foreign currency derivative contracts
9,300

 

 
9,300

 

Other long-term assets:
 
 
 
 
 
 
 
Deferred compensation plan assets
145,508

 
145,508

 

 

Total assets
$
563,872

 
$
554,572

 
$
9,300

 
$

Liabilities
 
 
 
 
 
 
 
Accounts payable and accrued liabilities:
 
 
 
 
 
 
 
Foreign currency derivative contracts
$
11,755

 
$

 
$
11,755

 
$

Total liabilities
$
11,755

 
$

 
$
11,755

 
$



Assets/Liabilities Measured at Fair Value on a Non-Recurring Basis
Non-Marketable Equity Securities
Equity investments in privately-held companies, also called non-marketable equity securities are accounted for using either the cost or equity method of accounting.
The non-marketable equity securities are measured and recorded at fair value when an event or circumstance which impacts the fair value of these securities indicates an other-than-temporary decline in value has occurred.  In such events, these equity investments would be classified within Level 3 as they are valued using significant unobservable inputs or data in an inactive market, and the valuation requires management judgment due to the absence of market price and inherent lack of liquidity. The non-marketable equity securities are measured and recorded at fair value when an event or circumstance which impacts the fair value of these securities indicates an other-than-temporary decline in value has occurred. The Company monitors these investments and generally uses the income approach to assess impairments based primarily on the financial conditions of these companies.
The Company did not recognize any impairment during the three and six months ended April 30, 2015 and 2014, respectively.
As of April 30, 2015, the fair value of the Company’s non-marketable securities was $10.9 million, of which $6.7 million and $4.2 million were accounted for under the cost method and equity method, respectively. As of October 31, 2014, the fair value of non-marketable securities was $10.9 million, of which $6.7 million and $4.2 million were accounted for under the cost method and equity method, respectively.